Stonepine Capital Management, LLC Amryt Pharma PLC Transaction History

Stonepine Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$7.0 - $14.77 $386,078 - $814,624	-55,154 Reduced 0.87%	6,278,085 $91.5 Million
Q4 2022 Feb 14, 2023	BUY	$6.68 - $7.58 $704,780 - $799,735	105,506 Added 1.69%	6,333,239 $46.2 Million
Q3 2022 Nov 10, 2022	SELL	$6.8 - $8.01 $480,182 - $565,626	-70,615 Reduced 1.12%	6,227,733 $43.1 Million
Q2 2022 Aug 12, 2022	SELL	$6.85 - $8.87 $272,986 - $353,487	-39,852 Reduced 0.63%	6,298,348 $44 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $10.86 $1.69 Million - $2.92 Million	268,425 Added 4.42%	6,338,200 $52.4 Million
Q4 2021 Feb 14, 2022	BUY	$9.44 - $12.24 $2.53 Million - $3.28 Million	268,027 Added 4.62%	6,069,775 $65.6 Million
Q3 2021 Nov 12, 2021	BUY	$9.63 - $12.47 $28.9 Million - $37.5 Million	3,004,004 Added 107.37%	5,801,748 $69.9 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.29 $2.99 Million - $3.92 Million	274,016 Added 10.86%	2,797,744 $33.9 Million
Q1 2021 May 14, 2021	BUY	$13.04 - $14.75 $14.4 Million - $16.3 Million	1,107,245 Added 78.17%	2,523,728 $35.2 Million
Q4 2020 Feb 12, 2021	BUY	$12.22 - $14.16 $7.96 Million - $9.22 Million	651,247 Added 85.1%	1,416,483 $20.1 Million
Q3 2020 Nov 13, 2020	BUY	$10.8 - $13.5 $8.26 Million - $10.3 Million	765,236 New	765,236 $9.46 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.